Skip to content

VD Pharma

Active Risk: low Limited partnershipfounded 2018active for 8 yearsDe Ster 20, 2540 HoveKBO/BCE: BE 0700.556.170
VD Pharma
Follow ReportCompare

Board

1 director, last change in 2023
Virginie DUGARDYN
Manager and general partner
appointed by deed of 23-08-2023 term without a fixed end

Office holders in the KBO →

Mandates through the years

1 name, the dashed line is today
Virginie DUGARDYN
Manager and general partner
Board
Mandates as a list
  • Virginie DUGARDYN
    • Manager and general partner, appointed by deed of 23-08-2023, still in office

Control

Shareholder
Virginie DUGARDYN
This company
VD Pharma

Articles of association

deed of 23-08-2023 (in Dutch)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Board ruleThese rules set how the board is made up, meets and takes decisions.
At least 1 director
“Gecommanditeerde vennoot of derde”
Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
“Artikel_5.179_en_5.180_BW, onderling akkoord bij gebreke deskundige aangewezen door voorzitter ondernemingsrechtbank”
Financial yearThe company draws up its annual accounts over this twelve-month period.
From 1 January to 31 December
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Second Friday of June at 13:00

Founder

Stated in the deed deed of 23-08-2023 ↗

Capital transactions

Capital over time
  1. 23-08-2023 Capital stated in the deed · 1,000 shares

Next steps

See this company's board, registered office and name on a given date.Company as of a date See what became of the directors' other companies.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file

We would like to set cookies. That happens only with your consent. What we measure